CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
0.3887
2.83%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0052
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026346 %
Charges from full value of position ($-5.01)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026346%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004124 %
Charges from full value of position ($0.78)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.4
Open* 0.3987
1-Year Change* -49.69%
Day's Range* 0.3867 - 0.3987
52 wk Range 0.47-1.39
Average Volume (10 days) 90.28K
Average Volume (3 months) 4.89M
Market Cap 13.88M
P/E Ratio -100.00K
Shares Outstanding 26.70M
Revenue N/A
EPS -0.90
Dividend (Yield %) N/A
Beta 2.89
Next Earnings Date Mar 21, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 5, 2023 0.3887 -0.0131 -3.26% 0.4018 0.4018 0.3827
Dec 4, 2023 0.4000 0.0013 0.33% 0.3987 0.4038 0.3797
Dec 1, 2023 0.4037 -0.0150 -3.58% 0.4187 0.4267 0.4000
Nov 30, 2023 0.4187 -0.0100 -2.33% 0.4287 0.4307 0.4087
Nov 29, 2023 0.4287 -0.0231 -5.11% 0.4518 0.4536 0.4087
Nov 28, 2023 0.4487 0.0200 4.67% 0.4287 0.4875 0.4287
Nov 27, 2023 0.4337 -0.0441 -9.23% 0.4778 0.4877 0.4212
Nov 24, 2023 0.4787 -0.0310 -6.08% 0.5097 0.5130 0.4787
Nov 22, 2023 0.5098 -0.0059 -1.14% 0.5157 0.5187 0.5097
Nov 21, 2023 0.5187 -0.0130 -2.44% 0.5317 0.5318 0.5187
Nov 20, 2023 0.5317 -0.0070 -1.30% 0.5387 0.5487 0.5287
Nov 17, 2023 0.5387 0.0200 3.86% 0.5187 0.5588 0.5117
Nov 16, 2023 0.5388 -0.0019 -0.35% 0.5407 0.5408 0.5187
Nov 15, 2023 0.5422 0.0035 0.65% 0.5387 0.5422 0.5287
Nov 14, 2023 0.5334 -0.0053 -0.98% 0.5387 0.5588 0.5293
Nov 13, 2023 0.5438 0.0151 2.86% 0.5287 0.5439 0.5178
Nov 10, 2023 0.5287 0.0066 1.26% 0.5221 0.5357 0.4987
Nov 9, 2023 0.5356 0.0169 3.26% 0.5187 0.5382 0.5187
Nov 8, 2023 0.5457 0.0270 5.21% 0.5187 0.5457 0.5157
Nov 7, 2023 0.5281 0.0094 1.81% 0.5187 0.5378 0.5187

GeoVax Labs, Inc. Events

Time (UTC) Country Event
Wednesday, December 6, 2023

Time (UTC)

20:25

Country

US

Event

GeoVax Labs Inc at Emerging Growth Conference
GeoVax Labs Inc at Emerging Growth Conference

Forecast

-

Previous

-
Thursday, March 21, 2024

Time (UTC)

10:59

Country

US

Event

Q4 2023 GeoVax Labs Inc Earnings Release
Q4 2023 GeoVax Labs Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0.08153 0.3855 1.82366 1.1759 0.9632
Revenue 0.08153 0.3855 1.82366 1.1759 0.9632
Total Operating Expense 14.1101 18.9593 4.64047 3.54839 3.52592
Selling/General/Admin. Expenses, Total 4.98661 3.57715 2.19601 1.63767 1.64727
Research & Development 9.12348 15.5542 2.44446 1.91072 1.87865
Operating Income -14.0286 -18.5738 -2.81681 -2.37249 -2.56272
Interest Income (Expense), Net Non-Operating 0.00744 0.00345 -0.14125 0.00186 0.00262
Net Income Before Taxes -14.0211 -18.5703 -2.95807 -2.37063 -2.56009
Net Income After Taxes -14.0211 -18.5703 -2.95807 -2.37063 -2.56009
Net Income Before Extra. Items -14.0211 -18.5703 -2.95807 -2.37063 -2.56009
Net Income -14.0211 -18.5703 -2.95807 -2.37063 -2.56009
Income Available to Common Excl. Extra. Items -14.0211 -18.5703 -2.95807 -2.37063 -2.56009
Income Available to Common Incl. Extra. Items -14.0211 -18.5703 -2.95807 -2.37063 -2.56009
Diluted Net Income -14.0211 -18.5703 -2.95807 -2.37063 -2.56009
Diluted Weighted Average Shares 16.9732 6.09993 1.38383 0.00302 0.00001
Diluted EPS Excluding Extraordinary Items -0.82607 -3.04435 -2.1376 -784.951 -312999
Diluted Normalized EPS -0.82607 -3.07255 -2.1376 -784.951 -312999
Total Extraordinary Items
Unusual Expense (Income) 0 -0.17206
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0 0 0 0 0
Revenue 0 0 0 0 0
Total Operating Expense 6.17882 4.27061 5.3875 3.97053 2.24249
Selling/General/Admin. Expenses, Total 1.45909 1.45143 1.62294 1.24934 0.93531
Research & Development 4.71973 2.81919 3.76456 2.7212 1.30718
Operating Income -6.17882 -4.27061 -5.3875 -3.97053 -2.24249
Interest Income (Expense), Net Non-Operating 0.2512 0.2327 0.00369 0.00243 0.00079
Net Income Before Taxes -5.92762 -4.03792 -5.38381 -3.9681 -2.2417
Net Income After Taxes -5.92762 -4.03792 -5.38381 -3.9681 -2.2417
Net Income Before Extra. Items -5.92762 -4.03792 -5.38381 -3.9681 -2.2417
Net Income -5.92762 -4.03792 -5.38381 -3.9681 -2.2417
Income Available to Common Excl. Extra. Items -5.92762 -4.03792 -5.38381 -3.9681 -2.2417
Income Available to Common Incl. Extra. Items -5.92762 -4.03792 -5.38381 -3.9681 -2.2417
Diluted Net Income -5.92762 -4.03792 -5.38381 -3.9681 -2.2417
Diluted Weighted Average Shares 26.4436 26.3386 26.4378 23.4617 12.7217
Diluted EPS Excluding Extraordinary Items -0.22416 -0.15331 -0.20364 -0.16913 -0.17621
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.22416 -0.15331 -0.20364 -0.16913 -0.17621
Unusual Expense (Income) 0 0 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 28.9387 11.6291 10.2352 0.44726 0.6197
Cash and Short Term Investments 27.6127 11.4239 9.8838 0.28334 0.2597
Cash & Equivalents 27.6127 11.4239 9.8838 0.28334 0.2597
Total Receivables, Net 0 0.04901 0.18266 0.0686 0.12181
Accounts Receivable - Trade, Net 0 0.04901 0.18266 0.0686 0.12181
Prepaid Expenses 1.326 0.15624 0.16869 0.09532 0.23819
Total Assets 31.3479 11.7971 10.3939 0.46888 0.64206
Property/Plant/Equipment, Total - Net 0.23491 0.15694 0.14774 0.01061 0.01135
Other Long Term Assets, Total 2.17429 0.01101 0.01101 0.01101 0.01101
Total Current Liabilities 4.74789 5.43536 0.81031 2.01619 1.62483
Accounts Payable 1.74768 2.05753 0.2677 0.15265 0.12586
Accrued Expenses 3.00021 3.37783 0.35928 1.85104 1.23855
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 4.74789 7.43536 0.82505 2.04344 1.66441
Total Long Term Debt 0 0 0.01474 0.02724 0.03958
Total Equity 26.6 4.3617 9.56885 -1.57456 -1.02235
Preferred Stock - Non Redeemable, Net 0 0.0761 1.93243 1.97133
Common Stock 0.02634 0.00638 0.00383 0.0003 0.2189
Additional Paid-In Capital 104.971 68.7312 55.2945 39.3402 37.2643
Retained Earnings (Accumulated Deficit) -78.397 -64.3759 -45.8056 -42.8475 -40.4769
Total Liabilities & Shareholders’ Equity 31.3479 11.7971 10.3939 0.46888 0.64206
Total Common Shares Outstanding 26.3349 6.38154 3.8341 0.01499 0.00001
Total Preferred Shares Outstanding 0 0.0002 0.00427 0.00345
Property/Plant/Equipment, Total - Gross 0.84142 0.70716 0.6746
Accumulated Depreciation, Total -0.60651 -0.55022 -0.66325
Current Port. of LT Debt/Capital Leases 0 0.18333 0.0125 0.26042
Long Term Debt 0 0.01474 0.02724 0.03958
Other Liabilities, Total 0 2
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 14.8003 19.8272 25.9888 28.9387 36.1372
Cash and Short Term Investments 12.687 17.7889 23.8499 27.6127 34.677
Cash & Equivalents 12.687 17.7889 23.8499 27.6127 34.677
Total Receivables, Net 0 0
Accounts Receivable - Trade, Net 0 0
Prepaid Expenses 2.11325 2.03828 2.13897 1.326 1.46021
Total Assets 16.201 21.2491 27.4042 31.3479 38.5704
Property/Plant/Equipment, Total - Net 0.21295 0.22408 0.21759 0.23491 0.24898
Property/Plant/Equipment, Total - Gross 0.87141 0.86522 0.84142 0.84142 0.84142
Accumulated Depreciation, Total -0.65846 -0.64114 -0.62382 -0.60651 -0.59243
Other Long Term Assets, Total 1.18779 1.19779 1.19779 2.17429 2.18429
Total Current Liabilities 7.08169 4.08551 4.53906 4.74789 4.78941
Accounts Payable 4.2133 0.87113 1.288 1.74768 1.07942
Accrued Expenses 2.86839 3.21438 3.25106 3.00021 3.70998
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases
Total Liabilities 7.08169 4.08551 4.53906 4.74789 6.78941
Total Long Term Debt 0 0 0 0 0
Long Term Debt
Total Equity 9.11935 17.1635 22.8652 26.6 31.781
Preferred Stock - Non Redeemable, Net
Common Stock 0.0267 0.02644 0.02644 0.02634 0.02634
Additional Paid-In Capital 105.864 105.5 105.274 104.971 104.768
Retained Earnings (Accumulated Deficit) -96.7714 -88.3626 -82.4349 -78.397 -73.0132
Total Liabilities & Shareholders’ Equity 16.201 21.2491 27.4042 31.3479 38.5704
Total Common Shares Outstanding 26.6953 26.4436 26.4436 26.3349 26.3349
Total Preferred Shares Outstanding
Other Liabilities, Total 0 2
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -14.0211 -18.5703 -2.95807 -2.37063 -2.56009
Cash From Operating Activities -19.0302 -11.1964 -2.75057 -1.3985 -1.54303
Cash From Operating Activities 0.05628 0.03852 0.01966 0.00835 0.0198
Non-Cash Items 0.90207 0.40776 0.18865 0.3275 0.46972
Changes in Working Capital -5.96744 6.92762 -0.00081 0.63628 0.52754
Cash From Investing Activities -0.13426 -0.04772 -0.15679 -0.00761 0
Capital Expenditures -0.13426 -0.04772 -0.15679 -0.00761 0
Cash From Financing Activities 35.3533 12.7842 12.5078 1.42974 1.49
Issuance (Retirement) of Stock, Net 35.3533 12.8121 11.461 1.44 1.19
Net Change in Cash 16.1889 1.54007 9.60046 0.02364 -0.05303
Issuance (Retirement) of Debt, Net 0 -0.02786 1.04682 -0.01026 0.3
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -4.03792 -14.0211 -8.63732 -4.66921 -2.42752
Cash From Operating Activities -3.76287 -19.0302 -11.966 -8.16682 -4.33324
Cash From Operating Activities 0.01732 0.05628 0.04221 0.02454 0.01227
Non-Cash Items 0.24604 0.90207 0.6509 0.41233 0.20515
Changes in Working Capital 0.01169 -5.96744 -4.02176 -3.93447 -2.12315
Cash From Investing Activities 0 -0.13426 -0.13426 -0.08238 -0.06219
Capital Expenditures 0 -0.13426 -0.13426 -0.08238 -0.06219
Cash From Financing Activities 0 35.3533 35.3533 27.7278 9.22927
Issuance (Retirement) of Stock, Net 0 35.3533 35.3533 27.7278 9.22927
Issuance (Retirement) of Debt, Net 0 0 0 0
Net Change in Cash -3.76287 16.1889 23.2531 19.4786 4.83385
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.7643 730985 0 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.5635 413444 0 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6533 172750 0 2023-06-30 LOW
Dodd (David A) Individual Investor 0.5633 148957 35087 2023-08-25 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3704 97942 0 2023-06-30 LOW
Reynolds (Mark W) Individual Investor 0.2957 78184 10000 2023-08-18 LOW
McNally (Robert T) Individual Investor 0.2039 53925 0 2023-06-02 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.1898 50197 0 2023-06-30 LOW
Two Sigma Investments, LP Hedge Fund 0.1392 36805 20716 2023-06-30 HIGH
Chase (Randal D) Individual Investor 0.1385 36613 0 2023-06-02 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1294 34214 0 2023-06-30 LOW
McKee (Kelly T Jr.) Individual Investor 0.1091 28838 9653 2023-09-25
Virtu Americas LLC Research Firm 0.1025 27097 27097 2023-06-30 HIGH
Spencer (John N Jr) Individual Investor 0.0795 21024 0 2023-06-02
Welch & Forbes LLC Investment Advisor/Hedge Fund 0.0643 16994 0 2023-06-30 LOW
Kollintzas (Dean G) Individual Investor 0.0453 11987 0 2023-06-02 LOW
GSA Capital Partners LLP Hedge Fund 0.0428 11328 11328 2023-06-30 HIGH
Tower Research Capital LLC Hedge Fund 0.0399 10562 -194 2023-06-30 HIGH
Wells Fargo Advisors Research Firm 0.017 4500 120 2023-06-30 LOW
Osaic Holdings, Inc. Investment Advisor 0.0113 3000 0 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

GeoVax Labs, Inc. Company profile

About Geovax Labs Inc

GeoVax Labs, Inc. is a clinical-stage biotechnology company. The Company is focused on developing human vaccines and immunotherapies against infectious diseases and cancer using its platforms. Its product pipeline includes ongoing human clinical trials for COVID-19 and head and neck cancer. The Company is developing a number of vaccines and immunotherapies for prevention or treatment of infectious diseases and cancers. The Company’s product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02, GEO-EM01, GEO-LM01 and GEO-MM02. Its research and development programs include preventive vaccines against Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa) and malaria, as well as immunotherapies for multiple solid tumors. The Company’s wholly owned subsidiaries include GeoVax, Inc. and Immutak Oncology, Inc.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Geovax Labs Inc revenues decreased 79% to $386K. Net loss increased from $3M to $18.6M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development increase from $2.4M to $15.6M (expense), General and administrative increase of 63% to $3.6M (expense).

Equity composition

Common Stock $.001 Par, 04/11, 40M auth., 15,699,909 issd. Insiders control approx. 39.31%. IPO: NA. Private Placement: 1997, 4.4M shares @ $1. 9/06, Co. acq. by GeoVax, Inc. & name changed from Dauphin Technology, Inc. 04/10, 1-for-50 reverse split.

Industry: Biotechnology & Medical Research (NEC)

1900 Lake Park Drive
Suite 380
SMYRNA
GEORGIA 30080
US

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

XRP/USD

0.63 Price
+0.100% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

US100

15,918.20 Price
+0.310% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,021.14 Price
+0.070% 1D Chg, %
Long position overnight fee -0.0197%
Short position overnight fee 0.0115%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

43,735.50 Price
-0.610% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading